reseligo 10,8 mg implantat v napolnjeni injekcijski brizgi
alvogen ipco s.ar.l - goserelin - implantat - goserelin 10,8 mg / 1 brizga - goserelin
reseligo 3,6 mg implantat v napolnjeni injekcijski brizgi
alvogen ipco s.ar.l - goserelin - implantat - goserelin 3,6 mg / 1 brizga - goserelin
zoladex 10,8 mg implantat v napolnjeni injekcijski brizgi
astrazeneca ab - goserelin - implantat - goserelin 10,8 mg / 1 brizga - goserelin
zoladex 3,6 mg implantat v napolnjeni injekcijski brizgi
astrazeneca ab - goserelin - implantat - goserelin 3,6 mg / 1 brizga - goserelin
fertigest
vetpharma animal health -
porceptal
intervet international -
receptal
intervet international -
leptoprol 5 mg implantat v napolnjeni injekcijski brizgi
sandoz d.d. - levprorelin - implantat - levprorelin 5 mg / 1 brizga - levprorelin
firmagon
ferring pharmaceuticals a/s - degareliks - prostatične neoplazme - endokrini terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.